MedTrace Logo

Severe Leptospirosis in Non-tropical Areas

NCT03912506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2019-05-16

No results posted yet for this study

Summary

Leptospirosis is a worldwide zoonosis. The mortality of the disease is between 3,6% to 13%, and up to 48% for the severe leptospirosis.

Only few studies exist on severe leptospirosis and none major multicentre on leptospirosis in intensive care units in Europe. The investigators conduct a retrospective multi centric study in metropolitan France in order to identify the characteristic, the treatments and the prognostic factors associated with mortality of sever leptospirosis.

Conditions

  • Leptospirosis
  • Intensive Care Unit
  • Epidemiology
  • Alveolar Hemorrhage

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Jean Reignier, MD, PhD · Nantes University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-07
Primary Completion
2018-07-09
Completion
2018-07-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03912506 on ClinicalTrials.gov